These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16144670)

  • 1. Diffuse granulomatous mesenteric disease caused by intravesical bacillus Calmette-Guérin instillation masquerading as peritoneal carcinomatosis.
    Shapiro A; Vakar F; Kamat AM
    Urol Oncol; 2005; 23(5):352-3. PubMed ID: 16144670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma.
    Proctor DD; Chopra S; Rubenstein SC; Jokela JA; Uhl L
    Am J Gastroenterol; 1993 Jul; 88(7):1112-5. PubMed ID: 8317415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arthritis after BCG treatment of bladder cancer. A rare complication].
    Rødevand E; Faxvaag A; Ostensen M; Brevik B
    Tidsskr Nor Laegeforen; 1996 Nov; 116(27):3231-2. PubMed ID: 9011976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can early single dose instillation of epirubicin improve bacillus Calmette-Guerin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study.
    Cai T; Nesi G; Tinacci G; Zini E; Mondaini N; Boddi V; Mazzoli S; Bartoletti R
    J Urol; 2008 Jul; 180(1):110-5. PubMed ID: 18485394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulomatous balanoposthitis after intravesical Bacillus-Calmette-Guerin instillation therapy.
    Yusuke H; Yoshinori H; Kenichi M; Akio H
    Int J Urol; 2006 Oct; 13(10):1361-3. PubMed ID: 17010022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients.
    Yossepowitch O; Eggener SE; Bochner BH; Donat SM; Herr HW; Dalbagni G
    J Urol; 2006 Aug; 176(2):482-5. PubMed ID: 16813873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: a pilot study.
    Pan CW; Shen ZJ; Ding GQ
    J Urol; 2008 Apr; 179(4):1307-11; discussion 1311-2. PubMed ID: 18289576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression level of ligands for natural killer cell receptors predicts response to bacillus Calmette-Guerin therapy: a pilot study.
    Yutkin V; Pode D; Pikarsky E; Mandelboim O
    J Urol; 2007 Dec; 178(6):2660-4. PubMed ID: 17945285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editor's choice: Implications of isoniazid resistance in Mycobacterium bovis Bacillus Calmette-Guérin used for immunotherapy in bladder cancer.
    Watts MR; Taylor PC; Sintchenko V; Whelan CM; Farnsworth RH; Jones P; Jelfs P; Carr D; Goldberg H
    Clin Infect Dis; 2011 Jan; 52(1):86-8. PubMed ID: 21148524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined thermo-chemotherapy for recurrent bladder cancer after bacillus Calmette-Guerin.
    Nativ O; Witjes JA; Hendricksen K; Cohen M; Kedar D; Sidi A; Colombo R; Leibovitch I
    J Urol; 2009 Oct; 182(4):1313-7. PubMed ID: 19683278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder and penile lesions with inguinal adenopathy after intravesical Bacillus Calmette-Guerin (BCG) treatment.
    Yates J; Stein B
    Urology; 2007 Dec; 70(6):1223.e15-7. PubMed ID: 18158061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased infiltration of tumor associated macrophages is associated with poor prognosis of bladder carcinoma in situ after intravesical bacillus Calmette-Guerin instillation.
    Takayama H; Nishimura K; Tsujimura A; Nakai Y; Nakayama M; Aozasa K; Okuyama A; Nonomura N
    J Urol; 2009 Apr; 181(4):1894-900. PubMed ID: 19237175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal tuberculosis and granulomatous hepatitis secondary to treatment of bladder cancer with Bacillus Calmette-Guérin.
    Soylu A; Ince AT; Polat H; Yasar N; Ciltas A; Ozkara S; Tasci AI
    Ann Clin Microbiol Antimicrob; 2009 Apr; 8():12. PubMed ID: 19368735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analyte profiling of the early events and tissue conditioning following intravesical bacillus calmette-guerin therapy in patients with superficial bladder cancer.
    Bisiaux A; Thiounn N; Timsit MO; Eladaoui A; Chang HH; Mapes J; Mogenet A; Bresson JL; Prié D; Béchet S; Baron C; Sadorge C; Thomas S; Albert EB; Albert PS; Albert ML
    J Urol; 2009 Apr; 181(4):1571-80. PubMed ID: 19230924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vesical tuberculosis after Bacillus Calmette-Guerin intravesical instillation therapy for bladder cancer].
    Ohtake S; Kawaji K; Nakaigawa N; Inayama Y; Kubota Y
    Hinyokika Kiyo; 2013 Jul; 59(7):457-60. PubMed ID: 23945329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical instillation therapy with bacillus Calmette-Guérin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Guérin immunotherapy.
    Shintani Y; Sawada Y; Inagaki T; Kohjimoto Y; Uekado Y; Shinka T
    Int J Urol; 2007 Feb; 14(2):140-6. PubMed ID: 17302571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosinophilic cystitis induced by bacillus Calmette-Guerin (BCG) intravesical instillation.
    Hidoussi A; Slama A; Jaidane M; Zakhama W; Youssef A; Ben Sorba N; Mosbah AF
    Urology; 2007 Sep; 70(3):591.e9-10. PubMed ID: 17905131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A thoracic tuberculous spondylodisctis after intravesical BCG immunotherapy of bladder cancer - Case report and literature review.
    Dąbrowska M; Drabarek T; Muraszko-Klaudel A; Sławek J
    Neurol Neurochir Pol; 2015; 49(6):460-6. PubMed ID: 26652884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Henoch-Schönlein purpura after intravesical administration of bacillus Calmette-Guérin.
    Nan DN; Fernández-Ayala M; García-Ibarbia C; Gutiérrez-Santiago M; Hernández JL
    Scand J Infect Dis; 2005; 37(8):613-615. PubMed ID: 16138436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of peroxisome proliferator activated receptor-gamma in bacillus Calmette-Guérin bladder cancer therapy.
    Langle Y; Lodillinsky C; Belgorosky D; Sandes EO; Eiján AM
    J Urol; 2012 Dec; 188(6):2384-90. PubMed ID: 23088980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.